Cited by 854Vitamin C and Antioxidants ResearchCancer and biochemical researchCancer, Hypoxia, and Metabolism

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

Open access
Chen, Qi, Espey, Michael Graham, Sun, Andrew Y., Pooput, Chaya, Kirk, Kenneth L., Krishna, Murali C., Khosh, Deena Beneda, Drisko, Jeanne +1 more·2008·Proceedings of the National Academy of Sciences

Abstract

Ascorbic acid is an essential nutrient commonly regarded as an antioxidant. In this study, we showed that ascorbate at pharmacologic concentrations was a prooxidant, generating hydrogen-peroxide-dependent cytotoxicity toward a variety of cancer cells in vitro without adversely affecting normal cells. To test this action in vivo, normal oral tight control was bypassed by parenteral ascorbate administration. Real-time microdialysis sampling in mice bearing glioblastoma xenografts showed that a single pharmacologic dose of ascorbate produced sustained ascorbate radical and hydrogen peroxide formation selectively within interstitial fluids of tumors but not in blood. Moreover, a regimen of daily pharmacologic ascorbate treatment significantly decreased growth rates of ovarian (P < 0.005), pancreatic (P < 0.05), and glioblastoma (P < 0.001) tumors established in mice. Similar pharmacologic concentrations were readily achieved in humans given ascorbate intravenously. These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0804226105

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tumor cells are much more, although variably, sensitive to vitamin C, with EC50 of vitamin C below 20 mM in all tested cases of human and mouse cancer cells lines.

    “Tumor cells are much more, although variably, sensitive to vitamin C, with EC50 of vitamin C below 20 mM in all tested cases of human and mouse cancer cells lines [180,181].”

    From Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination (2021) · cites this paper as [181]

    The 'Range of Cancer Cell Sensitivity to Ascorbate-Derived Hydrogen Peroxide' section reports variable sensitivity: 75% of 43 tumor cell lines had an EC50 below 10 mM, while normal cells showed no cytotoxicity above 20 mM. It does not establish that every tested cancer cell line had an EC50 below 20 mM; that universal threshold is unsupported by the text of our copy (page unavailable). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The viability of healthy cells is not affected by vitamin C even at 20 mM concentration.

    “The viability of healthy cells is not affected by vitamin C even at 20 mM concentration, i.e., at common concentrations achieved by administration of high doses of vitamin C.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Hoffer LJ, et al. (2008) Phase I clinical trial of intravenous ascorbate in advanced malignancy. Annal Oncol, in press.

Cited by

Sorted by citations

Authors
Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M.
Affiliations
  • *Molecular and Clinical Nutrition Section and
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • National Institutes of Health (US)
  • University of Kansas Medical Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2008-08-12
Volume
105
Issue
32
Pages
11105-11109
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2119115728
Cited by
854
References
26
Citations by year
2026: 26 · 2025: 39 · 2024: 47 · 2023: 50 · 2022: 63 · 2021: 63 · 2020: 70 · 2019: 56 · 2018: 60 · 2017: 55 · 2016: 44 · 2015: 41 · 2014: 42 · 2013: 42 · 2012: 32
FWCI
38.80
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
vitamin C, pharmacologic ascorbate, pro-oxidants, hydrogen peroxide, ascorbyl radical, tumor xenografts, glioblastoma, ovarian cancer, pancreatic cancer, tumor interstitial fluid, microdialysis, cancer therapy, selective cytotoxicity
MeSH terms
Animals, Antineoplastic Agents, Antioxidants, Ascorbic Acid, Female, Humans, Hydrogen Peroxide, Infusions, Intravenous, Mice, Nude, Neoplasms, Prodrugs, Oxidants, Xenograft Model Antitumor Assays, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review